Jeremy Carmichael, Senior Vice President, Corporate Development, Head of Business Development, UKLinkedin
Rees et al., “Introduction to the themed collection on fragment-based drug discovery”; RSC Med. Chem 2022Jan 13, 2023
Walsh et al., “Fragment-to-Lead Medicinal Chemistry Publications in 2021”; J Med Chem 2023Jan 13, 2023
Martins et al., “A commentary on the use of pharmacoenhancers in the pharmaceutical industry and the implication for DMPK drug discovery strategies”; Xenobiotica 2022Dec 20, 2022
2022 ASH: Prolonged Survival in Bi-Allelic TP53-Mutated (TP53mut) MDS Subjects Treated with Oral Decitabine/Cedazuridine in the Ascertain Trial (ASTX727-02)Dec 12, 2022